Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,632,200 | 1,161,500 | 2,961,600 | 1,727,600 | 4,060,500 |
| Depreciation Amortization | 963,400 | 526,300 | 638,000 | 1,117,000 | 457,200 |
| Income taxes - deferred | -158,100 | -305,800 | -168,600 | -426,800 | 149,000 |
| Accounts receivable | 222,300 | 61,300 | -203,400 | 324,800 | 2,800 |
| Other Working Capital | -155,200 | -648,700 | -890,300 | -145,500 | -187,200 |
| Other Operating Activity | 370,900 | 752,600 | -953,000 | 1,042,800 | -252,500 |
| Operating Cash Flow | $2,875,500 | $1,547,200 | $1,384,300 | $3,639,900 | $4,229,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -153,700 | -277,000 | 342,300 | -258,100 | -424,800 |
| Net Acquisitions | -1,074,800 | -6,926,100 | N/A | 28,100 | -1,006,500 |
| Purchase Of Investment | 0 | -5,140,700 | -3,448,500 | -3,808,700 | -6,397,700 |
| Sale Of Investment | 551,500 | 8,288,500 | 4,661,300 | 3,498,900 | 7,374,300 |
| Purchase Sale Intangibles | -206,100 | -34,400 | -2,900 | -18,800 | -127,000 |
| Other Investing Activity | -122,200 | -45,700 | 21,500 | -23,900 | -153,900 |
| Investing Cash Flow | $-799,200 | $-4,101,000 | $1,576,600 | $-563,700 | $-608,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 997,200 | 0 | 0 | 2,967,400 |
| Debt Repayment | -650,000 | -809,900 | -1,002,200 | -170,000 | -1,500,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | -4,600 |
| Common Stock Repurchased | 0 | 0 | -750,000 | -1,800,000 | -6,679,100 |
| Other Financing Activity | -33,500 | -38,000 | 4,900 | -116,200 | -56,400 |
| Financing Cash Flow | $-683,500 | $149,300 | $-1,747,300 | $-2,086,200 | $-5,272,700 |
| Exchange Rate Effect | -67,700 | 35,100 | -55,700 | -59,800 | 69,000 |
| Beginning Cash Position | 1,049,900 | 3,419,300 | 2,261,400 | 1,331,200 | 2,913,700 |
| End Cash Position | 2,375,000 | 1,049,900 | 3,419,300 | 2,261,400 | 1,331,200 |
| Net Cash Flow | $1,325,100 | $-2,369,400 | $1,157,900 | $930,200 | $-1,582,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,875,500 | 1,547,200 | 1,384,300 | 3,639,900 | 4,229,800 |
| Capital Expenditure | -153,700 | -277,000 | -240,300 | -258,100 | -424,800 |
| Free Cash Flow | 2,721,800 | 1,270,200 | 1,144,000 | 3,381,800 | 3,805,000 |